Related Experiment Video

Updated: Jun 29, 2025

Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis
10:41

Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis

Published on: December 15, 2023

1.8K

Endoscopic duodenal mucosa ablation: the future of diabetes treatment?

Giovanni Musso1, Maurizio Cassader2, Roberto Gambino2

  • 1MECAU, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy.

Trends in Molecular Medicine
|March 29, 2024
PubMed

Keywords:
ReCETduodenal mucosal resurfacingelectroporation therapyrecellularization

More Related Videos

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors03:37

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

Published on: December 20, 2024

528
Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice08:50

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

566

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
321